Veracyte, Inc. (VCYT) Financials
Key financial figures for Veracyte, Inc. (Q2 2026).
Veracyte Inc. reported revenue of $150.3 million for Q2 FY2026, up 15.5% from the same period a year earlier. Net income was $25.5 million, or $0.31 per share. Operating margin came to 15.29%, against -4.05% a year earlier. Free cash flow for the period was $43.0 million. Across the last 5 reported quarters, quarterly revenue has risen from $130.2 million in Q2 FY2025 to $150.3 million in Q2 FY2026. The figures above are as filed, and the full income statement, balance sheet and cash flow history for Veracyte Inc. are on the SentiSense financials page.
- Revenue
- $150M
- Net Income
- $25M
- EPS
- $0.32
- Total Assets
- $1.5B
- Operating Cash Flow
- $46M
Recent quarters
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| Q2 FY2026 | $150M | $25M | $0.31 | 15.29% | $43M |
| Q1 FY2026 | $139M | $29M | $0.35 | 17.15% | $32M |
| Q4 FY2025 | $141M | $41M | $0.50 | 18.44% | $48M |
| Q3 FY2025 | $132M | $19M | $0.24 | 17.4% | $42M |
| Q2 FY2025 | $130M | -$980K | -$0.01 | -4.05% | $32M |
Recent fiscal years
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| FY2025 | $517M | $66M | $0.82 | 14.34% | $127M |
| FY2024 | $446M | $24M | $0.31 | 3.62% | $64M |
| FY2023 | $361M | -$74M | -$1.02 | -23.76% | $34M |
Frequently asked questions
What was Veracyte Inc.'s revenue last quarter?
Veracyte Inc. reported revenue of $150.3 million for Q2 FY2026, up 15.5% from the same period a year earlier.
Is Veracyte Inc. profitable?
Yes. Veracyte Inc. reported net income of $25.5 million for Q2 FY2026, a net margin of 16.96% on revenue.
How has Veracyte Inc.'s margin trended?
Operating margin was 15.29% in Q2 FY2026, compared with -4.05% in the same period a year earlier. The quarter by quarter series is on the SentiSense financials page.
How much free cash flow did Veracyte Inc. generate?
Veracyte Inc. generated free cash flow of $43.0 million in Q2 FY2026, after capital expenditure.
Full income statement, balance sheet and cash flow for Veracyte, Inc. on SentiSense, with up to forty quarters and twenty fiscal years of history.